NCT05266807View on ClinicalTrials.gov

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

PHASE3RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

April 1, 2027

Study Completion Date

January 31, 2028

Conditions
Clostridioides Difficile Infection
Interventions
DRUG

oral capsulized Fecal Microbiota Transplantation

FMT will be administered per os in the form of capsules containing faeces from a healthy donor. Capsules are manufactured at the CHUV pharmacy (University Hospital of Lausanne, Switzerland)

DRUG

Vancomycin or Fidaxomicin

Vancomycin or Fidaxomicin per os as initially prescribed per SoC

Trial Locations (7)

1011

RECRUITING

CHUV, Lausanne

1708

RECRUITING

HFR Fribourg - Hôpital cantonal, Fribourg

1950

RECRUITING

Institut central des hôpitaux, Sion

3010

RECRUITING

Inselspital Bern, Bern

4031

RECRUITING

Universitätsspital, Basel

8091

RECRUITING

Universitätsspital Zürich, Zurich

9007

RECRUITING

Kantonsspital St Gallen, HOCH, Sankt Gallen

All Listed Sponsors
lead

Benoit Guery

OTHER